MoneyWorks4Me

Shree Ganesh Remed. - Quaterly Results

18 Jan 2022 Evaluate
The Turnover for the quarter ended December 2021 of Rs. 211.28 millions increase by 59.29% from Rs. 132.64 millions.Profit for the quarter ended December 2021 rises by 51.64% to Rs. 42.02  millions from Rs. 27.71 millions.Operating profit for the quarter ended December 2021 rose to 66.56 millions as compared to 37.15 millions of corresponding quarter ended December 2020.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 211.28 132.64 59.29 507.30 337.11 50.49 490.82 584.26 -15.99
Other Income 8.79 5.45 61.28 24.27 19.37 25.30 20.95 41.78 -49.86
PBIDT 66.56 37.15 79.17 157.03 109.91 42.87 157.42 151.26 4.07
Interest 0.33 0.19 73.68 1.31 0.54 142.59 0.68 1.41 -51.77
PBDT 66.23 36.96 79.19 155.72 109.37 42.38 156.74 149.85 4.60
Depreciation 9.88 2.17 355.30 27.57 14.07 95.95 27.25 22.41 21.60
PBT 56.35 34.79 61.97 128.15 95.30 34.47 129.49 127.44 1.61
TAX 14.33 7.08 102.40 32.58 20.15 61.69 31.96 31.20 2.44
Deferred Tax -0.20 2.20 -109.09 -0.37 2.94 -112.59 -0.36 -0.56 -35.71
PAT 42.02 27.71 51.64 95.57 75.15 27.17 97.53 96.24 1.34
Equity 120.08 100.06 20.01 120.08 100.06 20.01 100.06 89.71 11.54
PBIDTM(%) 31.50 28.01 12.48 30.95 32.60 -5.06 32.07 25.89 23.89
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..